Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Identifying and managing younger women at high risk of cardiovascular disease.

Srivaratharajah K, Abramson BL.

CMAJ. 2019 Feb 11;191(6):E159-E163. doi: 10.1503/cmaj.180053. Review. No abstract available.

PMID:
30745400
2.

Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.

Berger JS, Abramson BL, Lopes RD, Heizer G, Rockhold FW, Baumgartner I, Fowkes FGR, Held P, Katona BG, Norgren L, Jones WS, Millegård M, Blomster J, Reist C, Hiatt WR, Patel MR, Mahaffey KW.

Vasc Med. 2018 Dec;23(6):523-530. doi: 10.1177/1358863X18775594. Epub 2018 Jul 11.

PMID:
29992857
3.

Smoking abstinence 1 year after acute coronary syndrome: follow-up from a randomized controlled trial of varenicline in patients admitted to hospital.

Windle SB, Dehghani P, Roy N, Old W, Grondin FR, Bata I, Iskander A, Lauzon C, Srivastava N, Clarke A, Cassavar D, Dion D, Haught H, Mehta SR, Baril JF, Lambert C, Madan M, Abramson BL, Eisenberg MJ; EVITA Investigators.

CMAJ. 2018 Mar 26;190(12):E347-E354. doi: 10.1503/cmaj.170377.

4.

Women and Peripheral Arterial Disease: A Review of Sex Differences in Epidemiology, Clinical Manifestations, and Outcomes.

Srivaratharajah K, Abramson BL.

Can J Cardiol. 2018 Apr;34(4):356-361. doi: 10.1016/j.cjca.2018.01.009. Epub 2018 Jan 31. Review.

PMID:
29571419
5.

Ethnic Differences in Visceral Adiposity Measured in Early Pregnancy.

Srivaratharajah K, Abramson BL, Jairam J, Park AL, Berger H, Ray JG.

J Obstet Gynaecol Can. 2018 Feb;40(2):193-198. doi: 10.1016/j.jogc.2017.06.039. Epub 2017 Sep 20.

PMID:
28941834
6.

Metabolic syndrome cluster does not provide incremental prognostic information in patients with stable cardiovascular disease: A post hoc analysis of the AIM-HIGH trial.

Lyubarova R, Robinson JG, Miller M, Simmons DL, Xu P, Abramson BL, Elam MB, Brown TM, McBride R, Fleg JL, Desvigne-Nickens P, Ayenew W, Boden WE; Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglycerides and Impact on Global Health Outcomes (AIM-HIGH) Investigators.

J Clin Lipidol. 2017 Sep - Oct;11(5):1201-1211. doi: 10.1016/j.jacl.2017.06.017. Epub 2017 Jul 5.

7.

Smokers and Postcessation Weight Gain After Acute Coronary Syndrome.

Dehghani P, Habib B, Windle SB, Roy N, Old W, Grondin FR, Bata I, Iskander A, Lauzon C, Srivastava N, Clarke A, Cassavar D, Dion D, Haught H, Mehta SR, Baril JF, Lambert C, Madan M, Abramson BL, Eisenberg MJ.

J Am Heart Assoc. 2017 Apr 18;6(4). pii: e004785. doi: 10.1161/JAHA.116.004785.

8.

Effect of gender on outcome of out of hospital cardiac arrest in the Resuscitation Outcomes Consortium.

Morrison LJ, Schmicker RH, Weisfeldt ML, Bigham BL, Berg RA, Topjian AA, Abramson BL, Atkins DL, Egan D, Sopko G, Rac VE; Resuscitation Outcomes Consortium Investigators.

Resuscitation. 2016 Mar;100:76-81. doi: 10.1016/j.resuscitation.2015.12.002. Epub 2015 Dec 17.

9.

Varenicline for Smoking Cessation in Hospitalized Patients With Acute Coronary Syndrome.

Eisenberg MJ, Windle SB, Roy N, Old W, Grondin FR, Bata I, Iskander A, Lauzon C, Srivastava N, Clarke A, Cassavar D, Dion D, Haught H, Mehta SR, Baril JF, Lambert C, Madan M, Abramson BL, Dehghani P; EVITA Investigators.

Circulation. 2016 Jan 5;133(1):21-30. doi: 10.1161/CIRCULATIONAHA.115.019634. Epub 2015 Nov 9.

PMID:
26553744
10.
11.

Managing menopause.

Reid R, Abramson BL, Blake J, Desindes S, Dodin S, Johnston S, Rowe T, Sodhi N, Wilks P, Wolfman W; MENOPAUSE AND OSTEOPOROSIS WORKING GROUP.

J Obstet Gynaecol Can. 2014 Sep;36(9):830-833. doi: 10.1016/S1701-2163(15)30487-4. English, French.

PMID:
25222364
12.

Canadian Cardiovascular Society guidelines for the diagnosis and management of stable ischemic heart disease.

Mancini GB, Gosselin G, Chow B, Kostuk W, Stone J, Yvorchuk KJ, Abramson BL, Cartier R, Huckell V, Tardif JC, Connelly K, Ducas J, Farkouh ME, Gupta M, Juneau M, O'Neill B, Raggi P, Teo K, Verma S, Zimmermann R; Canadian Cardiovascular Society.

Can J Cardiol. 2014 Aug;30(8):837-49. doi: 10.1016/j.cjca.2014.05.013. Epub 2014 May 28.

PMID:
25064578
13.

Cardiovascular risk in women: focus on hypertension.

Abramson BL, Melvin RG.

Can J Cardiol. 2014 May;30(5):553-9. doi: 10.1016/j.cjca.2014.02.014. Epub 2014 Feb 26. Review.

PMID:
24786446
14.

Temporal trends and referral factors for cardiac rehabilitation post-acute coronary syndrome in ontario: insights from the Canadian Global Registry of Acute Coronary Events.

Nguyen TN, Abramson BL, Galluzzi A, Tan M, Yan AT, Goodman SG; Canadian GRACE Investigators.

Can J Cardiol. 2013 Dec;29(12):1604-9. doi: 10.1016/j.cjca.2013.10.002. Epub 2013 Oct 5.

PMID:
24267803
15.

Hypertension analysis of stress reduction using mindfulness meditation and yoga: results from the HARMONY randomized controlled trial.

Blom K, Baker B, How M, Dai M, Irvine J, Abbey S, Abramson BL, Myers MG, Kiss A, Perkins NJ, Tobe SW.

Am J Hypertens. 2014 Jan;27(1):122-9. doi: 10.1093/ajh/hpt134. Epub 2013 Sep 14.

PMID:
24038797
16.

While hormone therapy unlikely harmful in younger postmenopausal women at low CV risk, protective effects cannot be claimed.

Abramson BL.

Evid Based Med. 2013 Oct;18(5):176-7. doi: 10.1136/eb-2012-101127. Epub 2013 Jan 17. No abstract available.

PMID:
23328969
17.

Hypertension Analysis of stress Reduction using Mindfulness meditatiON and Yoga (The HARMONY Study): study protocol of a randomised control trial.

Blom K, How M, Dai M, Baker B, Irvine J, Abbey S, Abramson BL, Myers M, Perkins N, Tobe SW.

BMJ Open. 2012 Mar 5;2(2):e000848. doi: 10.1136/bmjopen-2012-000848. Print 2012.

18.

Response by sex to statin plus ezetimibe or statin monotherapy: a pooled analysis of 22,231 hyperlipidemic patients.

Abramson BL, Benlian P, Hanson ME, Lin J, Shah A, Tershakovec AM.

Lipids Health Dis. 2011 Aug 22;10:146. doi: 10.1186/1476-511X-10-146.

20.

Effect of raloxifene on stroke and venous thromboembolism according to subgroups in postmenopausal women at increased risk of coronary heart disease.

Mosca L, Grady D, Barrett-Connor E, Collins P, Wenger N, Abramson BL, Paganini-Hill A, Geiger MJ, Dowsett SA, Amewou-Atisso M, Kornitzer M.

Stroke. 2009 Jan;40(1):147-55. doi: 10.1161/STROKEAHA.108.518621. Epub 2008 Oct 23.

21.

Cardiovascular risk factor awareness in a disadvantaged inner-city population--implications for preventive strategies.

Wong BM, Garcia Y, Barr A, Glazier RH, Abramson BL.

Can J Cardiol. 2008 Sep;24(9):677-82.

22.

A prospective, controlled multisite study of psychosocial and behavioral change following women's cardiac rehabilitation participation.

Grace SL, Grewal K, Arthur HM, Abramson BL, Stewart DE.

J Womens Health (Larchmt). 2008 Mar;17(2):241-8. doi: 10.1089/jwh.2007.0519.

23.

A prospective comparison of cardiac rehabilitation enrollment following automatic vs usual referral.

Grace SL, Scholey P, Suskin N, Arthur HM, Brooks D, Jaglal S, Abramson BL, Stewart DE.

J Rehabil Med. 2007 Apr;39(3):239-45.

24.

Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial.

Lespérance F, Frasure-Smith N, Koszycki D, Laliberté MA, van Zyl LT, Baker B, Swenson JR, Ghatavi K, Abramson BL, Dorian P, Guertin MC; CREATE Investigators.

JAMA. 2007 Jan 24;297(4):367-79. Erratum in: JAMA. 2007 Jul 4;298(1):40.

PMID:
17244833
25.

Cardiovascular health and aromatase inhibitors.

Pritchard KI, Abramson BL.

Drugs. 2006;66(13):1727-40. Review.

PMID:
16978036
26.

Referral to and discharge from cardiac rehabilitation: key informant views on continuity of care.

Grace SL, Krepostman S, Brooks D, Jaglal S, Abramson BL, Scholey P, Suskin N, Arthur H, Stewart DE.

J Eval Clin Pract. 2006 Apr;12(2):155-63.

27.

Design and rationale for a randomized, controlled trial of interpersonal psychotherapy and citalopram for depression in coronary artery disease (CREATE).

Frasure-Smith N, Koszycki D, Swenson JR, Baker B, van Zyl LT, Laliberté MA, Abramson BL, Lambert J, Gravel G, Lespérance F.

Psychosom Med. 2006 Jan-Feb;68(1):87-93. Erratum in: Psychosom Med. 2007 Mar-Apr;69(2):216.

PMID:
16449416
28.

Sex differences in depression after coronary artery bypass graft surgery.

Mitchell RH, Robertson E, Harvey PJ, Nolan R, Rodin G, Romans S, Abramson BL, Brister SJ, Ivanov J, Stewart DE.

Am Heart J. 2005 Nov;150(5):1017-25.

PMID:
16290990
29.

Coronary vasospasm: a case report and review of the literature.

Van Spall HG, Overgaard CB, Abramson BL.

Can J Cardiol. 2005 Sep;21(11):953-7. Review.

PMID:
16239980
30.

Canadian Cardiovascular Society Consensus Conference: peripheral arterial disease - executive summary.

Abramson BL, Huckell V, Anand S, Forbes T, Gupta A, Harris K, Junaid A, Lindsay T, McAlister F, Roussin A, Saw J, Teo KK, Turpie AG, Verma S; Canadian Cardiovascular Society.

Can J Cardiol. 2005 Oct;21(12):997-1006.

PMID:
16234879
31.

Illness perceptions among cardiac patients: relation to depressive symptomatology and sex.

Grace SL, Krepostman S, Brooks D, Arthur H, Scholey P, Suskin N, Jaglal S, Abramson BL, Stewart DE.

J Psychosom Res. 2005 Sep;59(3):153-60.

32.

Patient-provider communication regarding referral to cardiac rehabilitation.

Mitoff PR, Wesolowski M, Abramson BL, Grace SL.

Rehabil Nurs. 2005 Jul-Aug;30(4):140-6.

PMID:
15999858
33.

Increasing Internet use among cardiovascular patients: new opportunities for heart health promotion.

Wong BM, Yung BM, Wong A, Chow CM, Abramson BL.

Can J Cardiol. 2005 Mar 15;21(4):349-54.

PMID:
15838562
34.

Increasing patient-initiation of cardiac rehabilitation referral in female percutaneous coronary intervention patients.

Grace SL, Evindar A, Brooks D, Jaglal S, Abramson BL, Nolan R.

Can J Cardiovasc Nurs. 2005;15(1):23-7.

35.

Physician management preferences for cardiac patients: factors affecting referral to cardiac rehabilitation.

Grace SL, Evindar A, Abramson BL, Stewart DE.

Can J Cardiol. 2004 Sep;20(11):1101-7.

PMID:
15457306
36.

Hormone replacement therapy for the primary prevention of chronic diseases: recommendation statement from the Canadian Task Force on Preventive Health Care.

Wathen CN, Feig DS, Feightner JW, Abramson BL, Cheung AM; Canadian Task Force on Preventive Health Care.

CMAJ. 2004 May 11;170(10):1535-7. No abstract available.

37.

Postmenopausal hormone replacement therapy for primary prevention of cardiovascular and cerebrovascular disease. Recommendation statement from the Canadian Task Force on Preventive Health Care.

Abramson BL; Canadian Task Force on Preventive Health Care.

CMAJ. 2004 Apr 27;170(9):1388-9. No abstract available. Erratum in: CMAJ. 2004 May 25;170(11):1650.

38.

Acute and chronic effects of hormone replacement therapy on the cardiovascular system in healthy postmenopausal women.

Kirwan LD, MacLusky NJ, Shapiro HM, Abramson BL, Thomas SG, Goodman JM.

J Clin Endocrinol Metab. 2004 Apr;89(4):1618-29.

PMID:
15070921
39.

Management of congestive heart failure: a gender gap may still exist. Observations from a contemporary cohort.

Burstein JM, Yan R, Weller I, Abramson BL.

BMC Cardiovasc Disord. 2003 Feb 5;3:1.

40.

Postmenopausal hormone replacement therapy and the prevention of cardiovascular disease: a review.

Abramson BL.

J Cardiovasc Risk. 2002 Dec;9(6):309-14. Review.

PMID:
12478199
41.

Atrial natriuretic peptide augments the variability of sympathetic nerve activity in human heart failure.

Kubo T, Ando S, Picton P, Atchison DJ, Notarius CF, Pollard MJ, Abramson BL, Floras JS.

J Hypertens. 2001 Mar;19(3 Pt 2):619-26.

PMID:
11327638
42.

Stress perfusion/metabolism imaging: a pilot study for a potential new approach to the diagnosis of coronary disease in women.

Abramson BL, Ruddy TD, deKemp RA, Laramee LA, Marquis JF, Beanlands RS.

J Nucl Cardiol. 2000 May-Jun;7(3):205-12.

PMID:
10888390
43.

Hormone replacement therapy and cardiac prevention.

Abramson BL.

Circulation. 2000 Jun 13;101(23):E223-4. No abstract available.

PMID:
10851220
44.

Use of hormone replacement therapy among cardiac patients at a Canadian academic centre.

Wise MR, Stewart DE, Liu P, Abramson BL.

CMAJ. 1999 Jul 13;161(1):33-6.

45.

Effect of atrial natriuretic peptide on muscle sympathetic activity and its reflex control in human heart failure.

Abramson BL, Ando S, Notarius CF, Rongen GA, Floras JS.

Circulation. 1999 Apr 13;99(14):1810-5.

PMID:
10199876
46.

Angiotensin AT1 receptor blockade abolishes the reflex sympatho-excitatory response to adenosine.

Rongen GA, Brooks SC, Ando Si, Abramson BL, Floras JS.

J Clin Invest. 1998 Feb 15;101(4):769-76.

47.

Neural and hypotensive effects of angiotensin II receptor blockade.

Rongen GA, Brooks SC, Ando S, Dajani HR, Abramson BL, Floras JS.

Hypertension. 1998 Jan;31(1 Pt 2):378-83.

PMID:
9453332

Supplemental Content

Loading ...
Support Center